Results 111 to 120 of about 366 (159)

[Obesity and 2019-nCoV. A risky relationship]. [PDF]

open access: yesRev Clin Esp, 2020
Carretero Gómez J   +2 more
europepmc   +1 more source

GRUPO TERAPÊUTICO ONLINE COM PACIENTES COM HIPERCOAGULABILIDADE: TECNOLOGIAS INOVADORAS DE CUIDADO EM TEMPOS DE PANDEMIA

open access: yesHematology, Transfusion and Cell Therapy, 2020
Sola, P.P.B.   +7 more
openaire   +2 more sources

[Long-term persistence of post-COVID-19 symptoms: A two-year follow-up of a Primary Care cohort]. [PDF]

open access: yesAn Sist Sanit Navar
Barrera Martínez Y   +6 more
europepmc   +1 more source

[Hypereosinophilic syndrome, case report and diagnostic approach]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Medina-Marroquín R   +3 more
europepmc   +1 more source

[Medullary infarction secondary to endovascular treatment of thoracoabdominal aortic aneurysm] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Hernández Villarroel LA   +1 more
europepmc   +1 more source

SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients. [PDF]

open access: yesMed Intensiva (Engl Ed), 2020
Llau JV   +10 more
europepmc   +1 more source

Alteraciones hemorreológicas, fibrinolíticas e hipercoagulabilidad en la obesidad: Efecto de la pérdida ponderal.

open access: yes, 2007
RESUMEN Se ha demostrado que la obesidad es un factor de riesgo. Los factores de riesgo cardiovascular clásicos asociados a la misma no pueden explicar por sí solos todo el exceso de eventos cardiovasculares que presentan estos pacientes. Por otra parte, varios estudios han evidenciado la asociación entre obesidad y tromboembolismo venoso.
openaire   +1 more source

Home - About - Disclaimer - Privacy